NeoGenomics Stock Forecast for 2023 - 2025 - 2030

Updated on 03/28/2024

Stock Rating
8
Price Target
$20.00
Consensus
Outperform
Upside
25.55%
Analysts
9
Stock Rating
8
Upside
25.55%
Analysts
9
Price Target
$20.00

NeoGenomics Stock Forecast and Price Target

The average price target for NeoGenomics's stock lately set by several renowned analysts is $20.00, which would result in a potential upside of approximately 25.55% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of $30.00 and a low estimate of $18.00. If you are looking to invest in the stock, it's important to research and compare different companies.

$20.00

25.55% Upside

Outperform
Outperform

NeoGenomics Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, NeoGenomics's Price has fallen from $7.02 to $0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of $17.28, which would mean an increase of 100.00%. Over the next seven years, experts predict that NeoGenomics's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$17.28
2025 Fair Value Forecast
$19.22
2026 Fair Value Forecast
$21.37
2027 Fair Value Forecast
$23.76
2028 Fair Value Forecast
$26.42
2029 Fair Value Forecast
$29.37
2030 Fair Value Forecast
$32.66
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TMO Stock Forecast Thermo Fisher Scientific Outperform 10
$599.43 Buy/Sell $591.94 0.10%
ROG Stock Forecast Roche Holding Hold 16
CHF242.00 Buy/Sell CHF307.83 11.57%
ABT Stock Forecast Abbott Laboratories Outperform 9
$120.19 Buy/Sell $118.92 4.83%
NOVN Stock Forecast Novartis Outperform 10
CHF88.80 Buy/Sell CHF105.00 23.95%
ILMN Stock Forecast Illumina Outperform 16
$139.06 Buy/Sell $159.28 7.87%

NeoGenomics Revenue Forecast for 2023 - 2025 - 2030

In the last three years, NeoGenomics's Revenue has grown by 33.12%, rising from $444.45M to $591.64M. For next year, analysts predict Revenue of $633.52M, which would mean an increase of 7.08%. Over the next seven years, experts predict that NeoGenomics's Revenue will grow at a rate of 19.72%.

2024 Rev Forecast
$0.63B
2025 Rev Forecast
$0.69B
2026 Rev Forecast
$0.76B
2027 Rev Forecast
$0.70B
2028 Rev Forecast
$0.68B
2029 Rev Forecast
$0.68B
2030 Rev Forecast
$0.71B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LH Stock Forecast Laboratory Corp of America Hol... Outperform 11
$218.53 Buy/Sell $241.28 11.20%
HOLX Stock Forecast Hologic Outperform 8
$76.33 Buy/Sell $81.06 7.56%
DGX Stock Forecast Quest Diagnostics Outperform 10
$129.43 Buy/Sell $141.17 9.94%

NeoGenomics Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
6869 Stock Forecast Sysmex Outperform 18
¥7.99k Buy/Sell ¥8.90k 11.40%
EXAS Stock Forecast Exact Sciences Buy 8
$60.70 Buy/Sell $90.32 44.98%
NTRA Stock Forecast Natera Outperform 7
$89.28 Buy/Sell $74.41 6.41%

NeoGenomics Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
QGEN Stock Forecast QIAGEN N.V. Outperform 15
$45.02 Buy/Sell $0.00 11.57%
SHL Stock Forecast Sonic Healthcare Hold 18
$28.47 Buy/Sell $34.12 8.89%
GH Stock Forecast Guardant Health Buy 6
$18.99 Buy/Sell $43.00 136.97%

NeoGenomics EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, NeoGenomics's EBITDA has gone down from $23.80M to $-24.07M – a 201.13% drop. In the next year, 11 analysts estimate that NeoGenomics's EBITDA will decrease by 173.66%, reaching $17.73M. For the next seven years, experts predict that NeoGenomics's EBITDA will grow at a rate of 1624.89%.

2024 EBITDA Forecast
$0.02B
2025 EBITDA Forecast
$0.05B
2026 EBITDA Forecast
$0.10B
2027 EBITDA Forecast
$-17414586.67
2028 EBITDA Forecast
$-50444833.20
2029 EBITDA Forecast
$-145906635.54
2030 EBITDA Forecast
$-415182194.98
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MYGN Stock Forecast Myriad Genetics Hold 6
$22.58 Buy/Sell $22.08 10.72%
VCYT Stock Forecast Veracyte Outperform 11
$22.66 Buy/Sell $32.17 43.42%
OPK Stock Forecast OPKO Health Outperform 8
$1.01 Buy/Sell $6.70 296.04%

NeoGenomics EBIT Forecast for 2023 - 2025 - 2030

NeoGenomics's EBIT has seen impressive growth In the last three years, rising from $-11.92M to $-96.65M – a growth of 710.82%. According to 11 analysts, NeoGenomics's EBIT will fall by 13.69% in the next year, reaching $-83.42M. Professionals believe that By 2030, NeoGenomics's EBIT will fall to $-68.97M – a 28.64% decrease from its current value.

2024 EBIT Forecast
$-83420000.00
2025 EBIT Forecast
$-74400000.00
2026 EBIT Forecast
$-15900000.00
2027 EBIT Forecast
$-36882700.00
2028 EBIT Forecast
$-76611515.02
2029 EBIT Forecast
$-142796202.84
2030 EBIT Forecast
$-68970565.97
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
FLGT Stock Forecast Fulgent Genetics Hold 16
$22.91 Buy/Sell $31.50 9.12%
ADPT Stock Forecast Adaptive Biotechnologies Outperform 6
$3.78 Buy/Sell $8.67 71.96%
CDNA Stock Forecast CareDx, Inc Outperform 9
$11.31 Buy/Sell $11.80 6.10%

NeoGenomics EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, NeoGenomics's EPS has fallen from $0.15 to $0.00 – a 100.00% decrease. For next year, analysts predict EPS of $-0.11, which would mean an increase of 100.00%. Over the next seven years, experts predict that NeoGenomics's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$-0.11
2025 EPS Forecast
$0.08
2026 EPS Forecast
$0.48
2027 EPS Forecast
$-0.19
2028 EPS Forecast
$-0.21
2029 EPS Forecast
$-0.39
2030 EPS Forecast
$-0.77
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
A038290 Stock Forecast Macrogen Buy 11
₩22.15k Buy/Sell ₩30.00k 35.44%
ATOS Stock Forecast Atossa Genetics Inc Buy 5
$1.20 Buy/Sell $4.83 233.33%
CRDF Stock Forecast Cardiff Oncology Buy 10
$4.04 Buy/Sell $8.37 114.85%